Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore which index funds have the lowest fees for retirement in 2024 and how expense ratios impact long-term growth. This intro explains why fee selection matters.
27,284 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Investors are watching amazon's next move into big-box retail with caution and curiosity. This article breaks down wh...
As humanoid robots scale from labs to factories, two equipment makers rise as the hidden winners in the trillion-doll...
Two market behemoths, two roadmaps: Palantir’s enterprise AI software and SanDisk’s hyperscale memory hardware race t...
AI’s power needs are lifting uranium miners into mainstream focus, aided by the URA ETF as nuclear energy gains renew...
When CODA reports its Q2 2026 results, the focus shifts from headlines to signals—backlog, margins, and customer wins...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
A large new study finds boosted homework scores when AI is used for assignments, yet exam results and college admissi...
Bittensor's TAO price prediction cycle returns as its AI-driven network expands, with new forecasts for 2025-2030 and...
Cogent’s Q4 2025 results show steady growth with improving margins and cautious guidance for 2026. This article inter...
Apple’s next AI chapter hinges on Siri. If the so-called this "siri-ous" problem could derail AI progress, investors ...